113 related articles for article (PubMed ID: 35792728)
1. Glyceraldehyde-derived advanced glycation end-products are associated with left ventricular ejection fraction and brain natriuretic peptide in patients with diabetic adverse cardiac remodeling.
Yasuda Y; Aoki H; Fujita W; Fujibayashi K; Wakasa M; Kawai Y; Nakanishi H; Saito K; Takeuchi M; Kajinami K
Scand Cardiovasc J; 2022 Dec; 56(1):208-216. PubMed ID: 35792728
[No Abstract] [Full Text] [Related]
2. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products.
Matsui T; Joo HD; Lee JM; Ju SM; Tao WH; Higashimoto Y; Fukami K; Yamagishi S
Immunol Lett; 2015 Oct; 167(2):141-6. PubMed ID: 26304702
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
Mao Z; Baker JR; Takeuchi M; Hyogo H; Tjønneland A; Eriksen AK; Severi G; Rothwell J; Laouali N; Katzke V; Kaaks R; Schulze MB; Palli D; Sieri S; de Magistris MS; Tumino R; Sacerdote C; Derksen JWG; Gram IT; Skeie G; Sandanger TM; Quirós JR; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Guevara M; Harlid S; Johansson I; Perez-Cornago A; Freisling H; Gunter M; Weiderpass E; Heath AK; Aglago E; Jenab M; Fedirko V
Int J Cancer; 2023 Jun; 152(11):2257-2268. PubMed ID: 36715363
[TBL] [Abstract][Full Text] [Related]
4. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
Takino J; Kobayashi Y; Takeuchi M
J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
[TBL] [Abstract][Full Text] [Related]
5. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
6. Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
Sotokawauchi A; Nakamura N; Matsui T; Higashimoto Y; Yamagishi SI
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283652
[TBL] [Abstract][Full Text] [Related]
7. Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.
Takeda M; Ohnuma T; Takeuchi M; Katsuta N; Maeshima H; Takebayashi Y; Higa M; Nakamura T; Nishimon S; Sannohe T; Hotta Y; Hanzawa R; Higashiyama R; Shibata N; Gohda T; Suzuki Y; Yamagishi S; Tomino Y; Arai H
Neurosci Lett; 2015 Apr; 593():51-5. PubMed ID: 25766756
[TBL] [Abstract][Full Text] [Related]
8. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
9. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.
Takino J; Yamagishi S; Takeuchi M
World J Gastroenterol; 2012 Apr; 18(15):1781-8. PubMed ID: 22553402
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy.
Kainuma S; Taniguchi K; Toda K; Shudo Y; Takeda K; Funatsu T; Miyagawa S; Kondoh H; Nishi H; Yoshikawa Y; Fukushima S; Hamada S; Kubo K; Daimon T; Sawa Y
J Cardiol; 2015 Oct; 66(4):279-85. PubMed ID: 25851471
[TBL] [Abstract][Full Text] [Related]
11. Presence of glyceraldehyde-derived advanced glycation end-products in the liver of insulin-resistant mice.
Ebata Y; Takino J; Tsuchiya H; Sakabe T; Ikeda Y; Hama S; Kogure K; Takeuchi M; Shiota G
Int J Vitam Nutr Res; 2013; 83(2):137-41. PubMed ID: 24491887
[TBL] [Abstract][Full Text] [Related]
12. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
[TBL] [Abstract][Full Text] [Related]
13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum BNP and ET-1 levels with cardiac pump function and ventricular remodeling in patients with heart failure.
Qin L; Liu X; Li Y
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):125-131. PubMed ID: 32538758
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Takeuchi M; Yamagishi S
Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
[TBL] [Abstract][Full Text] [Related]
16. Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products.
Watanabe M; Kawai Y; Kitayama M; Akao H; Motoyama A; Wakasa M; Saito R; Aoki H; Fujibayashi K; Tsuchiya T; Nakanishi H; Saito K; Takeuchi M; Kajinami K
J Cardiol; 2017 Apr; 69(4):625-631. PubMed ID: 27470137
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.
Gu L; Jiang W; Zheng R; Yao Y; Ma G
Cardiology; 2021; 146(1):27-33. PubMed ID: 33264784
[TBL] [Abstract][Full Text] [Related]
18. Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products.
Takino J; Yamagishi S; Takeuchi M
J Oncol; 2010; 2010():739852. PubMed ID: 20631911
[TBL] [Abstract][Full Text] [Related]
19. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
